Twelve pathways, including p53 signaling pathway, cell cycle, FoxO signaling pathway, viral carcinogenesis, and chronic myeloid leukemia, were identified in both HCHD and ECHD groups. This evidence concerns the gene TP53 and chronic myelogenous leukemia, BCR-ABL1 positive.